| Dr Scott Michael Smearman, OD | |
|
2023 Pulaski Highway, Havre De Grace, MD 21078 | |
| (410) 939-6477 | |
| (410) 939-6555 |
| Full Name | Dr Scott Michael Smearman |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 23 Years |
| Location | 2023 Pulaski Highway, Havre De Grace, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083616205 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | TA1732 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Retina Group Of Washington, Pllc | 5294702692 | 67 |
News Archive
Biogen Idec and Elan Corporation, plc today announced that the Committee for Medicinal Products for Human Use has adopted a positive opinion for inclusion of an additional risk factor, anti-JC virus (JCV) antibody status, to the product label for TYSABRI in the European Union.
New research published today, 10th July 2017, online in the journal Oncogene could offer hope to the thousands of, mainly young, people affected by the hereditary condition Neurofibromatosis 2 (NF2).
The National Marfan Foundation is gearing up for its 28th Annual conference, held at Northwestern Memorial Hospital in Chicago, August 2-5. Hosted by Northwestern Medicine- and the Ann and Robert H. Lurie Children's Hospital of Chicago, the four-day conference has something for everyone with Marfan syndrome (MFS) and related disorders, including access to many of the top MFS experts in the world.
Seattle Genetics, Inc. announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc. The milestone was triggered by Agensys' initiation of a phase I trial for AGS-16M8F, an ADC for the treatment of cancer utilizing Seattle Genetics' technology.
New research has revealed that though the death rate for U.S. men with diabetes has fallen sharply since the early 1970s, for women that is not the case.
› Verified 4 days ago
| Provider Name | Seidenberg Protzko Eye Associates |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1124065800 PECOS PAC ID: 9133173040 Enrollment ID: O20050303000457 |
News Archive
Biogen Idec and Elan Corporation, plc today announced that the Committee for Medicinal Products for Human Use has adopted a positive opinion for inclusion of an additional risk factor, anti-JC virus (JCV) antibody status, to the product label for TYSABRI in the European Union.
New research published today, 10th July 2017, online in the journal Oncogene could offer hope to the thousands of, mainly young, people affected by the hereditary condition Neurofibromatosis 2 (NF2).
The National Marfan Foundation is gearing up for its 28th Annual conference, held at Northwestern Memorial Hospital in Chicago, August 2-5. Hosted by Northwestern Medicine- and the Ann and Robert H. Lurie Children's Hospital of Chicago, the four-day conference has something for everyone with Marfan syndrome (MFS) and related disorders, including access to many of the top MFS experts in the world.
Seattle Genetics, Inc. announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc. The milestone was triggered by Agensys' initiation of a phase I trial for AGS-16M8F, an ADC for the treatment of cancer utilizing Seattle Genetics' technology.
New research has revealed that though the death rate for U.S. men with diabetes has fallen sharply since the early 1970s, for women that is not the case.
› Verified 4 days ago
| Provider Name | The Retina Group Of Washington, Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1225001654 PECOS PAC ID: 5294702692 Enrollment ID: O20100312000017 |
News Archive
Biogen Idec and Elan Corporation, plc today announced that the Committee for Medicinal Products for Human Use has adopted a positive opinion for inclusion of an additional risk factor, anti-JC virus (JCV) antibody status, to the product label for TYSABRI in the European Union.
New research published today, 10th July 2017, online in the journal Oncogene could offer hope to the thousands of, mainly young, people affected by the hereditary condition Neurofibromatosis 2 (NF2).
The National Marfan Foundation is gearing up for its 28th Annual conference, held at Northwestern Memorial Hospital in Chicago, August 2-5. Hosted by Northwestern Medicine- and the Ann and Robert H. Lurie Children's Hospital of Chicago, the four-day conference has something for everyone with Marfan syndrome (MFS) and related disorders, including access to many of the top MFS experts in the world.
Seattle Genetics, Inc. announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc. The milestone was triggered by Agensys' initiation of a phase I trial for AGS-16M8F, an ADC for the treatment of cancer utilizing Seattle Genetics' technology.
New research has revealed that though the death rate for U.S. men with diabetes has fallen sharply since the early 1970s, for women that is not the case.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Scott Michael Smearman, OD 2023 Pulaski Highway, Havre De Grace, MD 21078 Ph: (410) 939-6477 | Dr Scott Michael Smearman, OD 2023 Pulaski Highway, Havre De Grace, MD 21078 Ph: (410) 939-6477 |
News Archive
Biogen Idec and Elan Corporation, plc today announced that the Committee for Medicinal Products for Human Use has adopted a positive opinion for inclusion of an additional risk factor, anti-JC virus (JCV) antibody status, to the product label for TYSABRI in the European Union.
New research published today, 10th July 2017, online in the journal Oncogene could offer hope to the thousands of, mainly young, people affected by the hereditary condition Neurofibromatosis 2 (NF2).
The National Marfan Foundation is gearing up for its 28th Annual conference, held at Northwestern Memorial Hospital in Chicago, August 2-5. Hosted by Northwestern Medicine- and the Ann and Robert H. Lurie Children's Hospital of Chicago, the four-day conference has something for everyone with Marfan syndrome (MFS) and related disorders, including access to many of the top MFS experts in the world.
Seattle Genetics, Inc. announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc. The milestone was triggered by Agensys' initiation of a phase I trial for AGS-16M8F, an ADC for the treatment of cancer utilizing Seattle Genetics' technology.
New research has revealed that though the death rate for U.S. men with diabetes has fallen sharply since the early 1970s, for women that is not the case.
› Verified 4 days ago
Holloway Eye Care & Optique Optometrist Medicare: Medicare Enrolled Practice Location: 2015-c Pulaski Highway, Havre De Grace, MD 21078 Phone: 410-939-7717 Fax: 410-939-7739 | |
Meredith Katherine Clark, O. D. Optometrist Medicare: Medicare Enrolled Practice Location: 920 Revolution St, Havre De Grace, MD 21078 Phone: 410-939-2200 Fax: 410-939-5980 | |
Dr. Jessica A Wieser, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2023 Pulaski Hwy, Havre De Grace, MD 21078 Phone: 410-939-6477 Fax: 410-939-6555 | |
Jayro Loya Grijalva, OD Optometrist Medicare: Medicare Enrolled Practice Location: 2023 Pulaski Hwy, Havre De Grace, MD 21078 Phone: 410-939-6477 | |
Dr. David D Reed, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2023 Pulaski Highway, Havre De Grace, MD 21078 Phone: 410-939-6477 Fax: 410-939-6555 | |
Dr. Patricia Vivian Jones, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2023 Pulaski Hwy, Havre De Grace, MD 21078 Phone: 410-939-6477 |